Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01024127 · ClinicalTrials.gov registry record
Studying DNA in Blood and Bone Marrow Samples From Younger Patients With Acute Myeloid Leukemia
A clinical trial, sponsored by Children's Oncology Group.
- Completed
- Registry status
- 2,500
- Enrollment target
NCT01024127: Completed study, sponsored by Children's Oncology Group.
NCT01024127 is a clinical trial that has completed, run by Children's Oncology Group. The registered enrollment target is 2,500 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01024127 has completed, sponsored by Children's Oncology Group.
- COMPLETED
- Registry status
- 2,500 participants
- Enrollment target
Study Summary
This research trial studies deoxyribonucleic acid (DNA) in blood or bone marrow samples from younger patients with acute myeloid leukemia. Studying samples of blood and bone marrow from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. It may also help doctors predict how well patients will respond to treatment.
Interventions
- OTHER Laboratory Biomarker Analysis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,500 participants |
| Start Date | 2009-12 |
What the finished NCT01024127 record still lists
NCT01024127 is an observational study that tracks outcomes without assigning an intervention. Its 2,500 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which Laboratory Biomarker Analysis is the first listed.
NCT01024127 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01024127 about?
NCT01024127 is a clinical study titled "Studying DNA in Blood and Bone Marrow Samples From Younger Patients With Acute Myeloid Leukemia". This research trial studies deoxyribonucleic acid (DNA) in blood or bone marrow samples from younger patients with acute myeloid leukemia. Studying samples of blood and bone marrow from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify bi...
What is the current status of trial NCT01024127?
This trial is currently completed. The enrollment target is 2,500 participants. The study started on 2009-12.
What interventions are being tested in trial NCT01024127?
The interventions under investigation include: Laboratory Biomarker Analysis (OTHER).
Who is sponsoring clinical trial NCT01024127?
This trial is sponsored by Children's Oncology Group, which has 342 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001160 · 2,500 participants
Studies on Tumors of the Thyroid
- NCT01904188 · 2,500 participants
Clinical Microbial Species & Antibiotic Resistance ID in ED Patients Presenting With Infection - is Rapid ID Possible & Accurate?
- NCT02257229 · 2,500 participants
Prospective Evaluation of Treatment for Clubfoot
- NCT02530658 · 2,500 participants
Next Generation Sequencing of Normal Tissues Prospectively in Pediatric Oncology Patients
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia